Stocks · US
REGN
XNAS
Regeneron Pharmaceuticals Inc
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E17.28x
P/B2.36x
P/S4.81x
EPS$42.04
ROE13.65%
ROA10.37%
Dividend yield0.51%
EV/EBITDA17.21x
Debt/Equity0.09
Free cash flow$3.8B
Returns and 52-week range
1W-1.57%
1M-10.75%
3M+11.44%
6M-2.83%
1Y+23.12%
YTD-4.84%
52W high$859.34
52W low$541.00
From 52W high-14.04%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| 모더나 | $81.1B | — | 12.00 | +28.79% |
| The Cigna Group | $71.7B | 11.17 | 1.68 | -2.88% |
| 엘리밴스 헬스 | $85.6B | 17.24 | 1.91 | -1.82% |
| 보스턴 사이언티픽 | $61.4B | 16.72 | 2.46 | -11.74% |
| 매케손 | $106.7B | 23.24 | — | +1.51% |
| Natera, Inc. Common Stock | $61.4B | — | 33.68 | +22.08% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.